Nichols D
Pharmacol Rev. 2016; 68(2):264-355.
PMID: 26841800
PMC: 4813425.
DOI: 10.1124/pr.115.011478.
Benneyworth M, Smith R, Barrett R, Sanders-Bush E
Psychopharmacology (Berl). 2005; 179(4):854-62.
PMID: 15645221
DOI: 10.1007/s00213-004-2108-z.
ROSECRANS J
Behav Genet. 1995; 25(2):187-96.
PMID: 7733859
DOI: 10.1007/BF02196927.
Buckholtz N
Naunyn Schmiedebergs Arch Pharmacol. 1980; 314(3):215-21.
PMID: 6164934
DOI: 10.1007/BF00498542.
Boakes R, Bradley P, Briggs I, Dray A
Br J Pharmacol. 1970; 40(2):202-18.
PMID: 5492893
PMC: 1702892.
DOI: 10.1111/j.1476-5381.1970.tb09914.x.
Alterations in the behavioral effects of LSD by pretreatment with para-chlorophenylalanine and alpha-methyl-para-tyrosine.
Appel J, Lovell R, Freedman D
Psychopharmacologia. 1970; 18(4):387-406.
PMID: 5491475
DOI: 10.1007/BF00402765.
LSD: its effect upon 5-hydroxytryptamine in embryonic development of Xenopus laevis.
Baker P
Experientia. 1971; 27(5):536-7.
PMID: 5132588
DOI: 10.1007/BF02147584.
Partial antagonism of the behavioural and neurochemical effects of phencyclidine by drugs affecting monoamine metabolism.
Tonge S, Leonard B
Psychopharmacologia. 1972; 24(4):516-20.
PMID: 5034506
DOI: 10.1007/BF00423442.
The subcellular distribution of lysergic acid diethylamide in the rat brain.
FARAGALLA F
Experientia. 1972; 28(12):1426-7.
PMID: 4654194
DOI: 10.1007/BF01957828.
Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
King A, Martin I, Melville K
Br J Pharmacol. 1974; 52(3):419-26.
PMID: 4458849
PMC: 1777004.
DOI: 10.1111/j.1476-5381.1974.tb08611.x.
Effect of LSD-25 and 1-methyl-d-lysergic acid butanolamide on rat brain and platelet serotonin levels.
Torre M, Bogetto F, Torre E
Psychopharmacologia. 1974; 36(2):117-22.
PMID: 4407808
DOI: 10.1007/BF00421783.
Evidence of catecholamine mediation in the "aberrant" behaviour induced by lysergic acid diethylamide (LSD) in the rat.
Dixon A
Experientia. 1968; 24(7):743-7.
PMID: 4387561
DOI: 10.1007/BF02138352.
A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats.
Cameron O, Appel J
Psychopharmacologia. 1973; 33(2):117-34.
PMID: 4272898
DOI: 10.1007/BF00429082.
The effect of L-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo.
Carlsson A, Lindqvist M
J Neural Transm. 1972; 33(1):23-43.
PMID: 4264576
DOI: 10.1007/BF01244726.
Monoamines in the brain under the influence of muscimol and ibotenic acid, two psychoactive principles of Amanita muscaria.
Waser P, LANGEMANN H, Lichtensteiger W
Psychopharmacologia. 1970; 18(1):1-10.
PMID: 4256992
DOI: 10.1007/BF00402378.
Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists.
Davis M
Psychopharmacology (Berl). 1987; 93(3):286-91.
PMID: 3124159
DOI: 10.1007/BF00187244.
Effects of single and multiple dose LSD on endogenous levels of brain tyrosine and catecholamines.
Smith R, Boggan W, Freedman D
Psychopharmacologia. 1975; 42(3):271-6.
PMID: 1161985
DOI: 10.1007/BF00421267.
Comparison of the action of lysergic acid diethylamide and apomorphine on the copulatory response in the female rat.
Eliasson M, Meyerson B
Psychopharmacology (Berl). 1976; 49(3):301-6.
PMID: 826947
DOI: 10.1007/BF00426833.
Hallucinogen-induced rotational behavior in rats.
Fleisher L, Glick S
Psychopharmacology (Berl). 1979; 62(2):193-200.
PMID: 111284
DOI: 10.1007/BF00427136.
Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide.
Green J, Johnson C, Weinstein H, Maayani S
Proc Natl Acad Sci U S A. 1977; 74(12):5697-701.
PMID: 23536
PMC: 431860.
DOI: 10.1073/pnas.74.12.5697.
